Information
-
Trademark
-
79377981
-
International Classifications
-
Filing Date
July 31, 2023
a year ago
-
Transaction Date
October 24, 2024
a month ago
-
Status Date
October 23, 2024
a month ago
-
Location Date
October 23, 2024
a month ago
-
Status Code
661
-
Current Location
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
Employee Name
CANTOR, JILLIAN
-
Attorney Docket Number
T-5106 US MP
Attorney Name
Jefferson F. Scher
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
5
Mark Identification
DERMATOPLEX
Case File Statements
- DM0000: The mark consists of the stylized wording "DERMATOPLEX".
- GS0051: Reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use to identify pathogens, infections, and infectious diseases; chemical preparations containing enzymes for medical purposes for treating infections and infectious diseases; chemical preparations containing enzymes for treating infections and infectious diseases for pharmaceutical, veterinary and medical purposes; enzyme preparations for pharmaceutical, veterinary and medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; diagnostic kits comprising diagnostic agents, preparations and substances for medical and veterinary use; diagnostic kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, all for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; none of the foregoing for use in or as a medicated shampoo
- GS0011: Chemical reagents for non-medical purposes; chemical reagents for scientific purposes; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; enzyme preparations for industrial purposes to identify pathogens, infections, and infectious diseases; enzymes for scientific and research purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; acids, namely, nucleic recombinant acids to identify pathogens, infections, and infectious diseases; polymerase for scientific purposes; none of the foregoing for use in promoting plant growth or in enhancing the effectiveness of plant nutrients
- GS0441: Medical services; human healthcare services in the field of diagnosis and identification of pathogens infections and infectious diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services in the field of DNA and genetic testing; medical diagnostic services in the nature of medical testing and analysis; molecular diagnostics testing for medical purposes; providing medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; analysis of medical diagnostic images and medical molecular tests
- GS0101: Surgical, medical and veterinary apparatus and instruments for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic testing apparatus and instruments for medical purposes, namely, for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical diagnostic apparatus for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Anatomic pathology specimen collection kit comprising glass slides, centrifuge tubes, formalin jars, coplin jars, insert to hold slides and jars, absorbent cloth, and printed instructions, all for medical use
- GS0421: Scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; research and development services in the field of chemistry; scientific research in the field of chemistry; research in the field of chemistry; research laboratory analysis services in the field of chemistry; development services in the field of medical diagnostic apparatuses; design of medical diagnostic apparatuses; research in the field of molecular sciences; data analysis for scientific research purposes in the field of scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services, for scientific research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific research purposes; providing reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services, for scientific research purposes; custom design and development of biochemical assays
Case File Event Statements
-
9/7/2023 - a year ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
9/8/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
9/12/2023 - a year ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
4/1/2024 - 8 months ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
4/3/2024 - 8 months ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/4/2024 - 8 months ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
4/23/2024 - 7 months ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
4/24/2024 - 7 months ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
5/12/2024 - 7 months ago
9 - LIMITATION OF GOODS RECEIVED FROM IB
Type: LIMG
-
5/13/2024 - 7 months ago
10 - REFUSAL PROCESSED BY IB
Type: RFNT
-
7/7/2024 - 5 months ago
11 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Type: LIME
-
8/12/2024 - 4 months ago
12 - ATTORNEY REVIEW COMPLETED
Type: ATRV
-
10/22/2024 - a month ago
17 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Type: ECDR
-
10/22/2024 - a month ago
13 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
10/22/2024 - a month ago
16 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
10/22/2024 - a month ago
14 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
10/22/2024 - a month ago
15 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
10/22/2024 - a month ago
18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
10/23/2024 - a month ago
20 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/23/2024 - a month ago
21 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/23/2024 - a month ago
19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA